ADCY10 |
adenylate cyclase 10 (soluble) |
−3.7 |
ASPN |
asporin |
−8.8 |
CD36 |
CD36 molecule (thrombospondin receptor) |
−3.9 |
CYP2C19 |
cytochrome P450, family 2, subfamily C, polypeptide 19 |
−9.6 |
CYP2C8 |
cytochrome P450, family 2, subfamily C, polypeptide 8 |
−2.4 |
CYP2C9 |
cytochrome P450, family 2, subfamily C, polypeptide 9 |
−5.9 |
FASN |
fatty acid synthase |
−2.6 |
GH1 |
growth hormone 1 |
−2.9 |
GHR |
growth hormone receptor |
−21.4 |
GNAS |
GNAS complex locus |
−15.1 |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
−2.4 |
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
−2.3 |
IL1R2 |
interleukin 1 receptor, type II |
−4.1 |
IL6 |
interleukin 6 (interferon, beta 2) |
−11.8 |
KRAS |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
−2.3 |
MAP2K3 |
mitogen-activated protein kinase kinase 3 |
−3.7 |
MAP3K7 |
mitogen-activated protein kinase kinase kinase 7 |
−2.3 |
MED1 |
mediator complex subunit 1 |
−2.3 |
NCOA3 |
nuclear receptor coactivator 3 |
−2.4 |
NFKBIE |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon |
−3.8 |
PLCE1 |
phospholipase C, epsilon 1 |
−2.9 |
PLCL1 |
phospholipase C-like 1 |
−31.2 |
PRKACA |
protein kinase, cAMP-dependent, catalytic, alpha |
−10.5 |
PRKACB |
protein kinase, cAMP-dependent, catalytic, beta |
−4.9 |
PRKAR2B |
protein kinase, cAMP-dependent, regulatory, type II, beta |
−3.2 |
REL |
v-rel reticuloendotheliosis viral oncogene homolog (avian) |
−14.7 |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
−13.5 |
RRAS |
related RAS viral (r-ras) oncogene homolog |
−2.3 |
SMAD4 |
SMAD family member 4 |
−3.6 |